Current Status of Oral Disease-Modifying Treatment Effects on Cognitive Outcomes in Multiple Sclerosis: A Scoping Review

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Lingua originaleEnglish
pagine (da-a)848-N/A
RivistaBioengineering
Volume10
DOI
Stato di pubblicazionePubblicato - 2023

Keywords

  • BICAMS
  • Brief International Cognitive Assessment for MS
  • PASAT
  • SDMT
  • cladribine
  • cognitive impairment
  • dimethyl fumarate
  • fingolimod
  • magnetic resonance imaging (MRI)
  • multiple sclerosis
  • neuropsychological assessment
  • ozanimod
  • paced auditory serial addition task
  • siponimod
  • symbol digit modality test
  • teriflunomide

Cita questo